Fundraising Fox

Jim Healy

Investor

Managing Partner at Sofinnova Ventures · Board director at Seaport Therapeutics · Board director at BioAge Labs

Menlo Park, California

Writes $100K – $5M checks · typically $1.5M

About

Jim Healy has spent about twenty years investing at Sofinnova, backing thirty-two companies in the biotechnology and healthcare space, many of which have gone public or been acquired. He holds a B.A. in Molecular Biology and a B.A. in Scandinavian Studies from UC Berkeley, and earned his MD and PhD in Immunology from Stanford University through the NIH Medical Scientist Training Program. Before Sofinnova, he worked at Bayer (Miles) and Sanderling, and has lectured on entrepreneurship at Stanford.

Contact· self-published, not guessed

Likely email· guessed from name + firm domain, not firm-published

Invests in

BiotechHealthtechMedical Devices

Board director at Seaport Therapeutics

Intro paths

→

In turn, Jim can intro founders to Seaport Therapeutics's investors below.

Seaport Therapeutics's investors · 5

ARCH Venture PartnersChicago · $50K – $250M checks · since 2024Foresite CapitalWest Hollywood · since 2024HAWKTAILSan Francisco · since 2024PureTech HealthBoston · since 2024Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2024

Co-founders at Seaport Therapeutics

DZDaphne Zohar
Daphne ZoharFounder, CEO and Board Member

Board director at BioAge Labs

Intro paths

→

In turn, Jim can intro founders to BioAge Labs's investors below.

BioAge Labs's investors · 9

Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2024Elad GilSan Francisco · $100K – $10M checks · since 2024Felicis VenturesSan Francisco · $500K – $15M checks · since 2024IA Seed VenturesBerkeley · since 2024Longitude CapitalMenlo Park · $10M – $30M checks · since 2024OrbiMedNew York · $1M – $75M checks · since 2024Pear VCSan Francisco · $150K – $4M checks · since 2024RA CapitalBoston · since 2024Sofinnova VenturesMenlo Park · $100K – $15M checks · since 2024

Co-founders at BioAge Labs

KFKristen Fortney, PhD
Kristen Fortney, PhDCo-Founder, CEO
EMEric Morgen, MD
Eric Morgen, MDCo-Founder, COO
KFKristen Fortney
Kristen FortneyExecutive Officer, Director

Investments

Board seats

ArriVent (AVBP)BioAge (BIOA)CinCor (CINC)Karuna (KRTX)Rapport (RAPP)Seaport (SPTX)

Investor

Amarin (AMRN)Apellis (APLS)Ascendis (ASND)AtsenaAudentes (BOLD)Auris (EARS)Bolt (BOLT)Durata (DRTX)Edge (PDSB)Hyperion (HPTX)Iterum (ITRM)Natera (NTRA)Nucana (NCNA)Obseva (OBSV)

Per the firm's website.

Colleagues at Sofinnova Ventures

Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures

Network2

Anders Hove
Partner at ACORN BIOVENTURES
David Allison
Managing Director at Westlake Village BioPartners

Investors connected to Jim in public investor directories — a warm-intro map.

Frequently asked questions

Who is Jim Healy?
Jim Healy has spent about twenty years investing at Sofinnova, backing thirty-two companies in the biotechnology and healthcare space, many of which have gone public or been acquired. He holds a B.A. in Molecular Biology and a B.A. in Scandinavian Studies from UC Berkeley, and earned his MD and PhD in Immunology from Stanford University through the NIH Medical Scientist Training Program. Before Sofinnova, he worked at Bayer (Miles) and Sanderling, and has lectured on entrepreneurship at Stanford.
Where does Jim Healy work?
Jim Healy is Managing Partner at Sofinnova Ventures and Board director at Seaport Therapeutics and Board director at BioAge Labs.
What does Jim Healy invest in?
Jim Healy invests in Biotech, Healthtech, Medical Devices.
What check size does Jim Healy write?
Jim Healy typically writes checks of $100K – $5M.
What boards does Jim Healy sit on?
Jim Healy holds tracked board seats at ArriVent (AVBP), BioAge (BIOA), CinCor (CINC), Karuna (KRTX), Rapport (RAPP), Seaport (SPTX).
What companies has Jim Healy invested in?
Investments tracked here include Amarin (AMRN), Apellis (APLS), Ascendis (ASND), Atsena, Audentes (BOLD), Auris (EARS), Bolt (BOLT), Durata (DRTX), Edge (PDSB), Hyperion (HPTX), Iterum (ITRM), Natera (NTRA), and 2 more.